Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

CUSIP: 03615A108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
19,607,843
Total 13F shares
1,278,556
Share change
+526,354
Total reported value
$18,270,029
Price per share
$14.29
Number of holders
27
Value change
+$7,489,629
Number of buys
11
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 03615A108?
CUSIP 03615A108 identifies ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q2 2023

As of 30 Jun 2023, Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,278,556 shares. The largest 10 holders included AIGH Capital Management LLC, VANGUARD GROUP INC, Worth Venture Partners, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Merit Financial Group, LLC, Wescott Financial Advisory Group, LLC, Sterling Investment Advisors, Ltd., Bank of New York Mellon Corp, and Redmond Asset Management, LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.